Merck KGaA Stock

Equities

MRK

DE0006599905

Pharmaceuticals

Market Closed - Xetra 11:35:28 2024-06-06 am EDT 5-day change 1st Jan Change
171.9 EUR +0.67% Intraday chart for Merck KGaA +2.02% +19.29%
Sales 2024 * 21.32B 23.23B Sales 2025 * 22.64B 24.66B Capitalization 74.74B 81.41B
Net income 2024 * 3.01B 3.28B Net income 2025 * 3.53B 3.85B EV / Sales 2024 * 3.8 x
Net Debt 2024 * 6.29B 6.85B Net Debt 2025 * 4.43B 4.83B EV / Sales 2025 * 3.5 x
P/E ratio 2024 *
24.9 x
P/E ratio 2025 *
21 x
Employees 62,345
Yield 2024 *
1.35%
Yield 2025 *
1.48%
Free-Float 29.71%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Merck KGaA

1 day+0.67%
1 week+2.02%
Current month+3.24%
1 month+13.09%
3 months+8.08%
6 months+6.14%
Current year+19.29%
More quotes
1 week
164.05
Extreme 164.05
173.05
1 month
151.95
Extreme 151.95
173.05
Current year
140.50
Extreme 140.5
173.05
1 year
134.30
Extreme 134.3
173.05
3 years
134.30
Extreme 134.3
231.50
5 years
76.22
Extreme 76.22
231.50
10 years
61.05
Extreme 61.05
231.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 20-07-12
Director of Finance/CFO 56 14-07-31
Director of Finance/CFO 54 19-04-25
Members of the board TitleAgeSince
Director/Board Member - -
Director/Board Member 61 12-04-30
Director/Board Member 62 90-12-31
More insiders
Date Price Change Volume
24-06-06 171.9 +0.67% 210,522
24-06-05 170.8 +2.65% 232,601
24-06-04 166.4 -0.66% 223,348
24-06-03 167.4 +0.57% 152,205
24-05-31 166.5 +1.12% 568,222

Delayed Quote Xetra, June 06, 2024 at 11:35 am EDT

More quotes
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
171.9 EUR
Average target price
186.1 EUR
Spread / Average Target
+8.24%
Consensus